Broadband Near Infrared Spectroscopy to Understand the Role of Brain Cytochrome C Oxidase in Bipolar Disorder
Part of paid clinical trials in New York, New York.
- Sponsor
- Martin Lan
- Study ID
- NCT07806227
- Phase
- PHASE4
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Bipolar Disorder Depression
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 60 Years
- Healthy Volunteers
- Accepted
Interventions
- Lurasidone (Latuda) — DRUGThe medication will be used to understand how the imaging signal changes when symptoms change during treatment.
Study Details
People with a diagnosis of bipolar disorder who are depressed will have a light-based imaging of the brain (Near Infrared Spectroscopy) before and after they have treatment for their depression with a standard, approved medication named lurasidone. They will also answer questions about their history, and give blood samples. The goal is to understand the role of mitochondrial activity in bipolar disorder. Healthy volunteers who have never had a psychiatric disorder will have the same procedures, but they will not receive the medication.
Key Dates
- First listed
- Sep 8, 2026
- Start date
- Nov 1, 2026
- Status verified
- Sep 2026
- Primary completion
- Jul 30, 2028
- Completion
- Jul 30, 2028
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Bipolar DisorderParticipants in a major depressive episode will receive standard treatment with lurasidone for six weeks. Doses can be adjusted based on clinical need.
- No Intervention: Healthy VolunteerHealthy Volunteers will have all research procedures, but will not receive medication treatment
Primary Outcome Measure
Bipolar Depression Rating Scale [ Time Frame: 6 weeks ]
Central Contacts
- Martin Lan646 774 7610
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| New York State Psychiatric Institute | New York | New York | 10032 | - |
Find similar trials in New York, NY
Related Studies
- Time Restricted Eating (TRE) in Bipolar DisorderRecruiting · Massachusetts General Hospital · Boston, Massachusetts